> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Lilly Suggests FDA Drug Communication Research Changes
- URL: https://www.fdaweb.com/lilly-suggests-fda-drug-communication-research-changes/
- Published: 2017-01-05T12:00:00.000Z
- Updated: 2026-09-14T21:58:15.000Z
- Author: David McFarland
- Tags: Drugs, FDA Policy/General, #legacy-id-D5137649

Lilly says that the research objectives and study approach for an FDA study of character-space-limited online prescription drug communication generally seem reasonable. The research is to examine two hypotheses, it says in a comment [letter](https://www.regulations.gov/contentStreamer?documentId=FDA-2016-N-3585-0004&attachmentNumber=1&disposition=attachment&contentType=pdf&ref=fdaweb.com). The first is that participants who see substantive risk information in character-space-limited communication, compared with link-only participants, will have greater retention of the risk included in the communication and higher perceived risk. The second hypothesis is that participants with a “search goal” compared with a “browse goal” will have greater retention of the benefit and risk information and higher perceived risk because they will be more likely to notice the character-space-limited communication and to link to the risk information.

The company offers several suggested improvements to the study questionnaire and study design.